Pulling SEC filings + quote and writing the call…

Brighthouse Financial, Inc.
Next earnings Aug 5, 2026 (after close) · consensus $4.80 EPS, $2.22B rev
Last earnings +0.1% on 2026-05-06
Pending Aquarian take-private dominates the story — fundamentals are secondary to merger close mechanics on these junior subordinated notes.
Middling fundamentals offset by an attractive price (~1259% below fair value) — worth a look on the value angle.
BHFAL is Brighthouse Financial's junior subordinated debt-linked listed security, and the 10-K makes clear the entire investment case now hinges on the November 6, 2025 Merger Agreement with Aquarian Parent. Stockholders approved on February 12, 2026, HSR expired, and the deal is 'expected to close in 2026' — but it still needs insurance-regulator approvals in Delaware, New York and Massachusetts plus FINRA Rule 1017 sign-off on Brighthouse Securities. Until those clear, the price reflects deal-close probability more than operating fundamentals, and the filing itself warns the stock 'may reflect a market assumption that the Merger will be completed' and would decline if it breaks.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $4.98B | $6.87B | $4.12B | $4.72B | $6.77B |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $1.64B | $3.88B | -$1.11B | $388M | $433M |
| Diluted EPS | $18.39 | $51.30 | -$18.39 | $4.64 | $5.71 |
| Net margin | 33.0% | 56.4% | -27.0% | 8.2% | 6.4% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results disclosed; routine governance items
Q1 2026 10-Q filed; operations continue under merger conduct restrictions
Q1 2026 earnings release issued ahead of pending Aquarian merger close
2026 proxy issued; governance disclosures alongside pending merger close
FY25 10-K: revenue $6.77B (+43%), equity +37%; merger pending in 2026
Q4/FY25 earnings: net income +12%, diluted EPS $5.71 (+23%)
Stockholders approved Aquarian merger agreement at special meeting
Q3 2025 10-Q filed; first quarterly disclosure under Aquarian deal
Q3 2025 10-Q filed; first quarterly disclosure under Aquarian deal
Sources: SEC EDGAR (CIK 0001685040, latest 10-Q filed 2026-05-07) · EODHD · analysis by claude-code · as of 6/25/2026, 1:34:52 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-06-02 | Wetzel Paul M. Director | Exercise | 2.84K | |
| 2026-06-02 | Inserra Michael J. Director | Exercise | 1.42K | |
| 2026-06-02 | CHAPLIN C EDWARD Director | Exercise | 4.56K | |
| 2026-06-02 | Zlatkus Lizabeth H Director | Exercise | 2.84K | |
| 2026-06-02 | Offereins Diane E Director | Exercise | 2.84K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1044 tracked peers · median